{"id":"W4408246183","doi":"10.1007/s10637-025-01518-7","title":"First-in-human, phase 1 dose escalation study of SL-279252, a hexameric PD1-Fc-OX40L fusion protein, in patients with advanced solid tumors and lymphoma","year":2025,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Neutropenia; Medicine; Cmax; Pharmacodynamics; Pharmacokinetics; Adverse effect; Maculopapular rash; Rash; Internal medicine; Gastroenterology; Area under the curve; Lymphoma; Pharmacology; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002544197,0.0001946647,0.000390447,0.0005036395,0.00007660097,0.00001813707,0.0000990263,0.00006250686,0.000143308],"category_scores_gemma":[0.0001648427,0.0001745344,0.00002879583,0.0009424374,0.000181323,0.0001788865,0.00007254416,0.0001703016,0.000003346197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002405996,"about_ca_system_score_gemma":0.0004943268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006383174,"about_ca_topic_score_gemma":0.0002753302,"domain_scores_codex":[0.9979962,0.00009949584,0.000537063,0.0004083334,0.0007174842,0.0002414369],"domain_scores_gemma":[0.9990922,0.0001125888,0.0001591178,0.0002632561,0.0002035361,0.0001693239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007111337,0.00705328,0.857108,0.0004106667,0.0001106985,0.00004179464,0.006547451,0.001084783,0.04223701,0.0003148047,0.0001741866,0.07780599],"study_design_scores_gemma":[0.04165766,0.002875437,0.9474066,0.000961363,0.00002489521,0.000001884932,0.0004977352,0.001497122,0.003482411,0.001188653,0.0002294,0.0001768425],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960232,0.00005860557,0.00001167817,0.0006373078,0.00002501871,0.002775435,0.000006973285,0.00002405284,0.0004377679],"genre_scores_gemma":[0.9976623,0.000004787844,0.0005776581,0.0001703909,0.00003014804,0.0001581717,0.00009711495,0.00002273977,0.00127671],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0902986,"threshold_uncertainty_score":0.7117307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01274599359576806,"score_gpt":0.3056246908301644,"score_spread":0.2928786972343963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}